N-(5-(4-(3-(Dimethylamino)propyl)-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)-2-methoxypyridin-3-yl)butane-1-sulfonamide

ID: ALA4243870

PubChem CID: 145985966

Max Phase: Preclinical

Molecular Formula: C23H32N4O5S

Molecular Weight: 476.60

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCS(=O)(=O)Nc1cc(-c2ccc3c(c2)N(CCCN(C)C)C(=O)CO3)cnc1OC

Standard InChI:  InChI=1S/C23H32N4O5S/c1-5-6-12-33(29,30)25-19-13-18(15-24-23(19)31-4)17-8-9-21-20(14-17)27(22(28)16-32-21)11-7-10-26(2)3/h8-9,13-15,25H,5-7,10-12,16H2,1-4H3

Standard InChI Key:  JVQSXLIUEHOXRH-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 33 35  0  0  0  0  0  0  0  0999 V2000
    2.6414   -4.6142    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0541   -3.9085    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.2366   -3.9039    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0583   -5.5470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0583   -6.3642    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7636   -6.7687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4688   -6.3642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4688   -5.5470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7636   -5.1343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1755   -6.7772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1723   -7.5953    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8754   -8.0049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8817   -6.3686    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5892   -6.7826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5826   -7.6025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2854   -8.0158    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.9993   -7.6139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0059   -6.7941    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2986   -6.3762    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.7173   -6.3920    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7636   -4.3171    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3494   -5.1405    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6429   -5.5511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3041   -5.5590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0500   -3.0913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7557   -2.6791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7515   -1.8619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4572   -1.4498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0146   -5.1552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0200   -4.3380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7305   -3.9341    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.7359   -3.1170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4354   -4.3475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  1  0
  4  9  2  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
 10 11  1  0
 10 13  2  0
 11 12  2  0
 12 15  1  0
 14 13  1  0
  7 10  1  0
 14 15  2  0
 14 19  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
  9 21  1  0
 21  2  1  0
  4 22  1  0
 22 23  1  0
 19 24  1  0
  2 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 24 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 31 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4243870

    ---

Associated Targets(Human)

SNU-638 (372 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 476.60Molecular Weight (Monoisotopic): 476.2093AlogP: 2.98#Rotatable Bonds: 11
Polar Surface Area: 101.07Molecular Species: BASEHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 7.87CX Basic pKa: 9.31CX LogP: 0.35CX LogD: -0.26
Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.53Np Likeness Score: -1.58

References

1. Dong FD, Liu DD, Deng CL, Qin XC, Chen K, Wang J, Song HR, Ding HW..  (2018)  Design, synthesis and biological evaluation of novel series of 2H-benzo[b][1,4]oxazin-3(4H)-one and 2H-benzo[b][1,4]oxazine scaffold derivatives as PI3Kα inhibitors.,  26  (14): [PMID:29937355] [10.1016/j.bmc.2018.06.022]

Source